Chronic liver disease (CLD) is a growing global health challenge, accounting for millions of deaths each year. Its major contributors include metabolic dysfunction-associated steatohepatitis (MASH), alcoholic liver disease (ALD), and hepatitis C virus infection.
Exploring the protective effects of HSD17B13 in hepatic steatosis
- Post author:
- Post published:November 8, 2024
- Post category:uncategorized
- Post comments:0 Comments